Why is 2026’s "AI-PDX" integration the definitive...

добавлена новая статья Health

2026-01-29 12:13:34 -

Why is 2026’s "AI-PDX" integration the definitive end for late-stage drug trial attrition?

The final highlight of 2026 is the use of Artificial Intelligence to analyze the massive amounts of data coming out of patient derived xenograft model studies. By feeding years of PDX response data into deep-learning models, 2026 researchers can now predict with 90% accuracy whether a drug candidate will fail in human trials before the first person is ever dosed. This "digital-biological"...

0 Комментарии 0 Поделились 50 Просмотры 0 предпросмотр